Related Experiment Video

Updated: Aug 19, 2026

Transradial Access Chemoembolization for Hepatocellular Carcinoma Patients
05:31

Transradial Access Chemoembolization for Hepatocellular Carcinoma Patients

Published on: September 20, 2020

Is postoperative calcium channel blocker therapy needed in patients with radial artery grafts?

Mario Gaudino1, Nicola Luciani, Giuseppe Nasso

  • 1Department of Cardiac Surgery, Catholic University, Rome, Italy. mgaudino@tiscali.it

The Journal of Thoracic and Cardiovascular Surgery
|March 5, 2005
PubMed

Insights

Routine calcium channel blocker therapy for patients with radial artery grafts does not improve graft patency or clinical outcomes. This study suggests prophylactic calcium channel blocker use in these patients is unsubstantiated.

Area of Science:

  • Cardiology
  • Vascular Surgery
  • Pharmacology

Background:

  • Radial artery grafts are commonly used in coronary artery bypass grafting.
  • Chronic calcium channel blocker (CCB) therapy is often prescribed post-surgery for radial artery grafts without strong evidence.
  • This study aimed to assess the clinical and angiographic impact of CCB therapy in these patients.

Purpose of the Study:

  • To evaluate the efficacy of calcium channel blocker therapy in patients with radial artery grafts.
  • To determine the effect of CCB therapy on graft patency and clinical outcomes during the first postoperative year.
  • To investigate the impact of CCB therapy on radial artery response to serotonin.

Main Methods:

  • A randomized controlled trial involving 100 patients with radial artery grafts.
  • Patients were assigned to receive either oral diltiazem (CCB therapy) or no CCB therapy.
  • Outcomes assessed at 1-year included clinical evaluation, myocardial scintigraphy, and angiography; serotonin infusion response was also studied in a subset.

Main Results:

  • No significant differences were observed in clinical outcomes, scintigraphic results, or graft patency rates between the CCB and no-CCB groups.
  • Radial artery grafts exhibited a spastic reaction to endovascular serotonin infusion, which was not mitigated by CCB therapy.
  • Angiographic and clinical follow-up at 1 year showed no benefit from CCB administration.

Conclusions:

  • Calcium channel blocker therapy initiated post-surgery does not enhance radial artery graft patency or improve clinical/scintigraphic outcomes.
  • The prophylactic use of calcium channel blockers in patients with radial artery grafts appears unsubstantiated based on these findings.
  • Further research may be needed to explore alternative management strategies for radial artery graft dysfunction.
Abstract

More Related Videos

Creating Radio-cephalic Arteriovenous Fistula in the Forearm with a Modified No-Touch Technique07:30

Creating Radio-cephalic Arteriovenous Fistula in the Forearm with a Modified No-Touch Technique

Published on: April 1, 2022

Related Concept Videos

Peripheral Artery Disease V: Postoperative Nursing Management01:23

Peripheral Artery Disease V: Postoperative Nursing Management

During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Antihypertensive Drugs: Action of Calcium Channel Blockers01:18

Antihypertensive Drugs: Action of Calcium Channel Blockers

Calcium ions are essential to contract smooth muscle cells in blood vessels. They enter these cells through voltage-dependent calcium channels, specifically L-type calcium channels in the cell membrane. These L-type calcium channels are integral to the excitation-contraction coupling process in smooth muscle. When a stimulus is received by smooth muscle cells, their membrane depolarizes. This alteration in membrane potential instigates the opening of L-type calcium channels. As a result,...
Aneurysm IV: Nursing Management01:22

Aneurysm IV: Nursing Management

Vigilant monitoring for aneurysm rupture is essential for patients undergoing aortic surgery.Preoperative Nursing ManagementContinuously monitor the patient for manifestations of aneurysm rupture, such as pallor, weakness, tachycardia, hypotension, abdominal, back, groin, or periumbilical pain, changes in consciousness, and a pulsating abdominal mass. Regularly assess the patient's peripheral pulses.Instruct the patient to consume a clear liquid diet the day before surgery and administer...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers01:26

Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers

Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...